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Abstract
Background: Atrial fibrillation (AF) is the commonest abnormal heart rhythm with significant 
related morbidity and mortality. Several pathophysiologic mechanisms have been advocated to 
explain the onset of AF. There has been increasing evidence that abnormalities of the autonomic 
nervous system (ANS) that includes sympathetic, parasympathetic and intrinsic neural network 
are involved in the pathogenesis of AF. This review will consider the anatomical and 
pathophysiological concepts of the cardiac neuronal network and discuss how it can be 
investigated.
Design: Relevant articles for this review were selected primarily from Ovid Medline and Embase 
databases. We searched for key terms ‘atrial fibrillation’, ‘AF’, ‘autonomic dysfunction’ 
‘autonomic nervous system’ ‘heart rate variability’ and ‘HRV’ to gather relevant studies. 
Duplicate papers were excluded.
Results: Heart is richly innervated by autonomic nerves. Both sympathetic and parasympathetic 
system interact in developing AF along with cardiac ganglionated plexi (GP). Thus autonomic 
dysfunction is present in AF. There are methods including selective ablation that reduce 
autonomic innervation and show to reduce the incidence of spontaneous or induced atrial 
arrhythmias. Heart rate variability (HRV) is a useful tool to assess sympathetic and 
parasympathetic influences on disease states. HRV can be improved following intervention and is 
thus a useful application in assessing autonomic dysfunction in patients with AF.
Conclusion: ANS plays a crucial role in the development, propagation and complexity of AF. 
Assessment of the autonomic involvement in the propagation of AF may help in explaining why 
certain patients with AF do not benefit from cardioversion or ablation.
Keywords: Autonomic nervous system; heart rate; autonomic dysfunction; vagal tone; atrial 
fibrillation
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Introduction
Atrial fibrillation (AF) is the commonest abnormal heart rhythm with significant related morbidity 
and mortality. From the general population, 1-2% is affected by AF, however the prevalence of 
this condition rises to approximately 10% in individuals aged > 75 years.1-3 There were 8.8 million 
adults with established AF in 2010 in Europe and this is expected to increase to 17.9 million by 
2060.3 AF is an independent risk factor for stroke.4 It is associated with a 5-fold increase in the 
risk of stroke, a 3-fold increase in the risk of heart failure and a 2-fold increase in the risk of 
death.1, 5
Several pathophysiologic mechanisms (such as neurohormonal activation, structural changes, 
fibrosis, atherosclerosis, etc.) have been advocated to explain the onset of AF.6 There has been 
increasing evidence that abnormalities of the autonomic nervous system (ANS) that includes 
sympathetic, parasympathetic and intrinsic neural network are involved in the pathogenesis of 
AF.7 This review will consider the anatomical and pathophysiological concepts of the cardiac 
neuronal network and discuss how it can be investigated.
Anatomy of the cardiac autonomic nervous system
The heart is richly innervated by the autonomic nerves. The ANS of the heart consists of intrinsic 
and extrinsic ganglia.8 The parasympathetic components of the extrinsic cardiac nervous system 
originate in the vagus nerve. The extrinsic sympathetic innervation is mediated via the cervical, 
stellate (cervicothoracic), and thoracic ganglia. Interestingly, vagus nerve also contains 
sympathetic fibres and conversely, parasympathetic fibres are also found in sympathetic 
nerves.9-11 
Baroreceptors, chemoreceptors and mechanical stress receptors located in the heart and great 
vessels regulate autonomic tone.8 Moreover, clusters of intrinsic ganglia form a complex neural 
network composed of ganglionated plexi (GP), which are situated in the atria in multiple 
locations and attenuate the interactions between the extrinsic and intrinsic nervous systems (see 
figure 1).12 GP are suitably innervated with both adrenergic and vagal nerve endings and are 
situated in fat pads, close to the pulmonary vein ostia. The cardiac neural control occurs at 
This article is protected by copyright. All rights reserved
several levels with each level capable of parallel processing of afferent neurotransmission and 
efferent cardiac sympathetic outflow.13 
Figure 1 – Cross sectional drawing of the heart showing the anatomical position of Ganglionated 
plexi (GP) (image obtained from Armour et al with permission)14
G.P = Ganglionated plexus, PA = Pulmonary artery, SVC = Superior vena cava, IVC = Inferior vena cava.
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Autonomic dysfunction in atrial fibrillation
There has been detailed exploration into the autonomic mechanisms underlying AF. Scherf and 
colleagues first proposed the theory of focal firing based on their observations that rapid firing of 
action potentials and/or AF occurred following application of either acetylcholine (ACh) or 
aconitine and it terminated once the source was removed by cooling.15, 16 Studies by Moe et al 
further demonstrated that AF could be initiated by premature beats during stimulation of the 
vagus nerve.17 Other basic science studies also showed that electrical stimulation of autonomic 
nerves innervating the heart could induce AF.18, 19  
Sympathetic system promote arrhythmia by increasing calcium transient in the synapses.20 
Calcium entry into the presynaptic neuron through voltage gated calcium channels is essential 
for neurotransmitter release. Activated -adrenergic signal pathways increase calcium entry into 
the presynaptic neuron and the spontaneous release of calcium from sarcoplasmic reticulum.20 
This leads to neurotransmitter release and thus increase in action potential frequency. 
On the other hand, vagal stimulation contributes to development of AF by heterogenous 
shortening of action potential duration and refractory period.7 ACh activates the muscarinic 
receptors (mainly M2 in the heart). This in turn modulate cardiac ionic channels through direct 
activation of IKACh (inward-rectifying potassium channel). IKACh is a G protein-gated ion channel 
found in the sinoatrial node and atria and contributes to the regulation of heart rate by 
accelerating repolarisation and leading to hyperpolarisation. It also exerts its effect through 
indirect regulation by modulation of cyclic adenosine monophosphate (cAMP) mediated 
responses, a second messenger used for intracellular signal transduction (such as transferring 
into cells the effects of hormones like glucagon and adrenaline, which cannot pass through the 
plasma membrane).21, 22 The overall result is shortening of action potential duration leading to 
AF.
Vagal stimulation has also been shown to cause conduction delays.23, 24 Additionally, recent 
studies have shown evidence of noncholinergic vagal effects that may also contribute to the 
pathogenesis of vagally induced AF.25, 26 These effects may be mediated by vagally released 
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polypeptide and vasoactive intestinal polypeptide (VIP), which enhance the delayed rectifier 
potassium current (IKs) and decrease sodium current and thus contribute to the vagal effects on 
atrial action potential duration and conduction velocities as well as increased propensity to AF.7 
It has been demonstrated that there is significant vagal innervation of the atrial muscle sleeves 
extending into the pulmonary veins and other thoracic veins.27 In normal heart, vagal influences 
are predominant, thus explaining that the clinical manifestation of vagal-mediated paroxysmal AF 
is preferentially seen in young male adults with absence of detectable heart disease.28 Their 
electrocardiogram (ECG) pattern is of common flutter alternating with fibrillation.28 Vagally 
mediated AF occurs more commonly in men than in women, and the onset of first episode is 
around 30 – 50 years of age.28 Sympathetically mediated AF is less common and observed in the 
presence of any heart disease, the first effect of which is to induce vagal withdrawal.28 
The anatomical distribution of the autonomic fibres is different for sympathetic and vagal 
innervation.28 Sympathetic and parasympathetic terminals lie in close proximity to one another, 
and both are close to the target cells, yet do not have an identical distribution.28 Thus stimulation 
of one system may affect function of the other.28 For example, noradrenaline release from 
sympathetic nerves is diminished by the acetylcholine released from neighbouring vagal nerves.28 
Furthermore, the latency time and duration of the physiological response of each sympathetic 
and parasympathetic also differs.28 The functional response to cholinergic stimulation occur 
within a few milliseconds whereas adrenergic stimulation requires seconds for target 
activastion.28 This combination of inhomogeneity of the autonomic effects in space and time 
contributes to the difficulty in managing AF. 
Previously, it was considered that sympathetic nervous system (SNS) drove most of exercise-
induced AF; however Coumel and colleagues describe that electrophysiological characteristics of 
atrial cells (including action potential duration and refractoriness, conduction speed) are 
modulated differently by sympathetic and vagal influences.28 The former tends to favour 
abnormal automaticity and triggered activity whereas the latter tends to influence macro re-
entry phenomena.28 
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Other studies have shown that both sympathetic and parasympathetic system interact in 
developing AF.29, 30 Additionally, cardiac GP may play a vital role in the pathogenesis of AF.7 
Clinically, the sites of ablation during PV isolation are often adjacent to the locations of GPs and 
PV isolation could lead to vagal denervation of the left atrium. Platt and colleagues were the first 
to describe that ablation of GPs may aid in terminating AF.31 This was further supported by other 
studies, demonstrating the feasibility of selectively targeting GPs to suppress AF.7, 32 Katritsis et al 
concluded that combination of PV isolation and GP ablation has higher success in suppressing AF 
when compared to PV isolation alone.33    
There is evidence to support that in addition to the atrial remodelling that takes place in patients 
with AF leading to ‘AF begets AF’ hypothesis; there is structural remodelling (apoptosis and 
scaring) and autonomic remodelling, all of which promote the propensity and prolongation of AF 
episodes.34, 35 The exact extent and mechanism(s) of such neural remodelling remain elusive. It is 
clear that autonomic dysfunction plays an important role in the pathogenesis of AF. There are 
methods that reduce autonomic innervation and thus show to reduce the incidence of 
spontaneous or induced atrial arrhythmias.36-40 This suggests that neuromodulation may be 
helpful in controlling AF. Studies looking at altering of the sympathetic limb of ANS showed that 
suppression of sympathetic tone leads to a notable reduction in atrial vulnerability to AF 
induction and post-ablation AF recurrence.41, 42
Role of heart rate variability
Exploring the ANS is possible through heart rate variability (HRV) evaluation. It is well established 
that short-term, respiratory related variation of cardiac cycle reflects vagal activity, whereas 
variation over prolonged periods reflect neurogenic and humoral modulation of the sympathetic 
tone.43 HRV is a non-invasive method to evaluate ANS activity and reflects the best ANS influence 
on heart rate.44-46 HRV is a measure which indicates the variation in the heartbeat within a 
specific time frame. It is measured by looking at the heart rate that changes over time against the 
average heart rate, and is expressed as time and spectrum analytical methods.47 It analyses 
variation in the beat to beat intervals of the heart and reflects the parasympathetic nervous 
system (PNS) and SNS balance.48 Variations in heart rate may be evaluated by a number of 
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methods but the commonly used methods in HRV are time domain and frequency domain. The 
most commonly used measures of each domain are presented in table 1.
Time domain indices of HRV quantify the amount of variability in measurements of the interbeat 
interval (IBI), which is the time period between successive heartbeats.48 Some of the common 
time domain metrics include SDNN, SDNN Index (SDNNI), RMSSD, NN50 and pNN50. Briefly, 
SDNN is the sum contribution of both SNS and PNS. It is more accurate when calculated over 24 
hours than during shorter periods and is the gold standard for medical stratification of cardiac 
risk when recorded over a 24 hour period.43 SDNN values predict both morbidity and mortality. 
Based on 24 hour recording, patients with SDNN values below 50 ms are classified as unhealthy, 
50 – 100 ms have compromised health, and above 100 ms are healthy.49 
SDANNI reflects autonomic influence on HRV and correlates with VLF power over a 24 hour 
period. RMSSD reflects the beat-to-beat variance in HR and is the primary time-domain measure 
used to estimate the vagally mediated changes reflected in HRV.50 24 hour RMSSD 
measurements strongly correlate with pNN50 and HF power.51 The RMSSD is more influenced by 
the PNS than SDNN. Lower RMSSD values correlate with high risk of sudden unexplained death in 
epilepsy.52
Frequency domain measurements are analogous to the electroencephalogram (EEG) where 
autoregressive modelling is used to separate HRV into its component ULF, VLF, LF and HF 
rhythms that operate within different frequency ranges. This concept is similar to a prism that 
reflects light into its component wavelengths.43 It includes ULF, VLF, LF, HF and LF/HF ratio. 
Briefly, ULF correlates highly with SDANN time-domain index and represents very slow-acting 
biological processes, core body temperature, metabolism and the renin-angiotensin system. VLF 
is more strongly associated with all cause mortality than LF or HF. Low VLF power has been 
associated with arrhythmic death, post traumatic stress disorder (PTSD), high inflammation, low 
levels of testosterone, heart’s intrinsic nervous system, physical activity, thermoregulatory, 
renin-angiotensin and endothelial influences on the heart.50, 53-59 PNS activity may contribute to 
VLF power since parasympathetic blockade almost completely abolishes it whereas SNS does not 
influence VLF power.43, 60
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In contrast, LF power is produced by both PNS and SNS as well as blood pressure regulation via 
baroreceptors.43, 58, 61 However, PNS is predominant in LF. Respiratory-related efferent vagally 
mediated influences are particularly present in the LF band, for example when taking a deep 
breath or sigh.62 The HF band reflects parasympathetic activity and is also referred to as the 
respiratory band as it corresponds to the heart rate variations related to the respiratory cycle. HF 
power is highly correlated with the pNN50 and RMSSD time-domain measures.63 HF power may 
increase at night and decrease during the day.64 Lower HF power is related to stress, panic or 
anxiety.        
It is believed that an increase of the PNS tone increases HRV while a vagal withdrawal may 
reduce HRV.44-46, 65 Low HRV is indicative of reduced cardiac parasympathetic function and is 
associated with worse cardiovascular outcomes.53, 66 In sinus rhythm, high HRV signifies a good 
cardiovascular adaptive response to various endogenous and exogenous factors.47 HRV is found 
to be lower in several cardiac and non cardiac disease states including coronary artery disease, 
congestive heart failure, hypertension, rheumatoid arthritis, aging and diabetic neuropathy 
amongst other.49, 53, 66-68 In the absence of direct intraneural recordings of cardiac autonomic 
activity in humans, HRV analysis has provided a useful indirect surrogate.69
AF is characterised by marked HRV. The patterns of atrial excitation in AF, the conduction 
properties of the atrioventricular node and the modulating effects of the ANS appear to be 
influential.70-73 HRV has been studied extensively in patients with normal sinus rhythm and 
shown to have important prognostic implications for various cardiovascular disorders (see table 
2).44, 49, 53, 74, 75 However, there have been relatively few published reports dealing with the 
phenomenon in AF.73, 76, 77 A study by Friedman showed that increasing left atrial size was 
associated with less HRV, suggesting a role of the left atrium in modulating the cardiovascular 
effects of the ANS.78 Other studies have shown use of HRV in AF and described that HRV indices 
correlate well with vagal tone.47, 73 They concluded that HRV in patients with AF is related to 
vagal tone.47, 73 HRV is thus a useful way of assessing autonomic dysfunction in patients with AF.
Conclusion
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The evidence shows that ANS plays a crucial role in the development, propagation and 
complexity of AF. The mechanisms underlying the process of autonomic dysfunction within the 
myocardium are intricate and perhaps, this explains why this concept has not received enough 
recognition. Assessment of the autonomic involvement in the propagation of AF may help in 
explaining why certain patients with AF do not benefit from cardioversion or ablation. The 
advent of non invasive techniques, such as heart rate variability has allowed to assess the role of 
ANS in AF in greater detail. There is further data to support that modulation of the ANS is 
possible and prudent. This may prove to be a useful addition in the management of AF along with 
existing therapy.
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Table 1 – Common time domain and frequency domain measures of HRV (adapted from 
Malik et al)48 
Variable Units Description 
Time domain measures 
NN interval ms Normal to normal interval 
SDNN ms Standard deviation of all NN intervals. 
SDANN ms Standard deviation of the averages of NN intervals in all 5 min 
segments of the entire recording. 
RMSSD ms The square root of the mean of the sum of the squares of differences 
between adjacent NN intervals. 
SDNN index ms Mean of the standard deviations of all NN intervals for all 5 min 
segments of the entire recording. 
SDSD ms Standard deviation of differences between adjacent NN intervals. 
NN50 count ms Number of pairs of adjacent NN intervals differing by more than 50 
ms in the entire recording. Three variants are possible, counting all 
such NN intervals pairs or only pairs in which the first or the second 
interval is longer. 
pNN50 % NN50 count divided by the total number of all NN intervals. 
Frequency domain measures 
5 min total 
power 
ms2 The variance of NN intervals over the temporal segment [Frequency 
range:  0.4 Hz] 
ULF ms2 Power in the ultra low frequency range [Frequency range:  0.003 
Hz] 
VLF ms2 Power in very low frequency range [Frequency range:  0.04 Hz] 
LF ms2 Power in low frequency range [Frequency range: 0.04 – 0.15 Hz] 
LF norm n.u. LF power in normalised units. LF/Total Power-VLF) x 100 
HF ms2 Power in high frequency range [Frequency range: 0.15 – 0.4 Hz] 
HF norm n.u. HF power in normalised units. HF/Total Power-VLF) x 100 
LF/HF ms2/ 
ms2 
Ratio of low frequency range and high frequency range 
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Table 2 – Utility of HRV in cardiovascular disease states and risk factor conditions 
Author(s) Year Condition 
studied 
Number 
of 
patients 
Summary 
Abdelnabi et 
al65 
2019 Coronary 
artery disease 
(CAD) 
100 Complete revascularisation during 
coronary angiography associated with 
improved HRV (p<0.001). 
Adlan et al55 2017 Rheumatoid 
arthritis 
63 Time (RMSSD, pNN50%) and frequency 
(high frequency (HF) power, low 
frequency (LF) power, total power) 
domain measures of HRV were lower in 
the RA, RA-hypertension and 
hypertension groups compared to 
controls (p=0.001). High sensitivity CRP 
(hs-CRP) and pain were independently 
and inversely associated with time 
domain parameters of HRV. 
Barauskiene 
et al47 
2016 Atrial 
fibrillation 
(AF) 
222 HRV significantly lower in AF patients 
(p<0.05). HRV was significantly higher in 
patients on betablockers than without 
(p<0.005). 
Bigger et 
al50 
1992 CAD 715 Each measure of HRV had a significant 
and at least moderately strong univariate 
association with all-cause mortality, 
cardiac death and arrhythmic death. 
Frey et al63 1995 Heart failure 
(HF) and AF 
35 SDANN was independently associated 
with survival on multivariate analysis. 
Dichotomized SDANN at 100 msec 
accurately predicted 12-month survival in 
28 patients (relative risk = 9.77, p=0.001) A
cc
ep
te
d 
A
rt
ic
le
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Friedman64 2004 AF 38 Reduced HRV correlated with increasing 
left atrial and left ventricular dimensions. 
Left atrial dimension is an independent 
determinant of HRV. HRV greater in lone 
AF than other cardiac disorders. 
Kearney et 
al61 
2002 HF 553 SDNN independent predictor of all-cause 
mortality. Hazard ratio (HR) of 
progressive HF death for a 10% decrease 
in SDNN was 1.06 (95% Confidence 
Interval (CI) 1.01-1.12). 
Kleiger et 
al54 
1987 CAD 808 SDNN had the strongest univariate 
correlation with mortality of all Holter 
variables. Relative risk of mortality was 
5.3 times higher in the group with SDNN 
< 50ms than the group with SDNN > 
100ms. 
La Rovere et 
al51 
1998 CAD 1284 SDNN < 70ms carried a significant 
multivariate risk of cardiac mortality (3.2 
[95% CI 1.42-7.36]) 
Marinkovic 
et al66 
2019 Paroxysmal AF 
(PAF) 
100 HRV changes during the 3-month period 
after catheter ablation for PAF may 
predict long-term outcomes. SDNN cut-
off value of 62.5 ms showed the best 
predictive ability for late recurrence AF 
(Area Under Curve (AUC) = 0.59 [95% CI 
0.27-0.49], p = 0.04) 
Mori et al67 2018 AF 54 Marked increase in HRV parameters 
observed immediately post cryoballoon 
ablation (CB) especially in patients who 
had left sided pulmonary vein (PV) 
isolation. 
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Rich et al68 1988 CAD 100 Decreased HRV and ejection fraction 
were the best predictors of mortality 
(p<0.01). HRV was an independent 
predictor of mortality.   
Singh et al52 1998 Hypertension 
(HTN) 
2042 HRV significantly lower in hypertensive 
men and women. LF associated with 
incident HTN in men (odds ratio (OR): 
1.38; 95% CI 1.04-1.83 but not in women 
(OR: 1.12; 95% CI 0.86-1.46). Lower HRV 
associated with greater risk of 
developing HTN among normotensive 
men. 
Stein et al60 1993 Mitral 
regurgitation 
(MR) 
38 Heart rate, ultra low frequency (ULF), LF 
and LF/HF predicted mortality, 
progression to surgery and development 
of permanent AF. SDANN was an 
independent predictor of poor outcomes 
(p=0.001). 
Stein et al62 1994 MR and AF 21 Reductions in measurements of ULF and 
HF were significant predictors of 
mortality or requirement for mitral valve 
surgery (p=0.02 and p=0.05 respectively).  
van den 
Berg et al59 
1997 AF 28 Baseline HRV was higher in AF group. 
After administration of methylatropine, 
HRV neared zero in the control group 
whereas it returned to baseline in AF 
group. SD, RMSSD, LF and HF at baseline 
were significantly (p<0.05) correlated 
with vagal tone in both groups. HRV in 
patients with AF related to vagal tone. 
Zysko et al69 1999 CAD and PAF 68 No isolated stimulation of 
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parasympathetic or sympathetic nervous 
system noted immediately prior to 
episode of PAF in patients with CAD. 
Cessation of PAF accompanied by 
increased RMSSD and pNN50.  
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Table 3 – Search strategy to look for articles containing atrial fibrillation and autonomic 
nervous system 
 
 Searches Results 
1  atrial fibrillation.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, 
nm, kf, ox, px, rx, an, ui, sy] 
204025 
2  af.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, 
rx, an, ui, sy] 
129908 
3  autonomic nervous system.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, 
kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy] 
121449 
4  autonomic dysfunction.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, 
dq, nm, kf, ox, px, rx, an, ui, sy] 
22430 
5  1 or 2 262475 
6  3 or 4 137164 
7  5 and 6 2104 
 
 
Table 4 – Search strategy to look for articles containing atrial fibrillation and heart rate 
variability 
 
 Searches Results 
1  atrial fibrillation.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, 
ox, px, rx, an, ui, sy] 
204025 
2  af.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, 
ui, sy] 
129908 
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3  heart rate variability.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, 
kf, ox, px, rx, an, ui, sy] 
49842 
4  HRV.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, 
ui, sy] 
26601 
5  1 or 2 262475 
6  3 or 4 54174 
7  5 and 6 1448 
 
Figure 2 – Flow diagram of process for identification of suitable studies to include in the 
review 
 
 
 
 
eci_13174_f2.doc
This	article	is	protected	by	copyright.	All	rights	reserved
